Cite
MLA Citation
J. Bargay et al.. “90 INTENSIVE CHEMOTHERAPY VERSUS NO INTENSIVE TREATMENT IN HIGH RISK MYELODYSPLASTYC SYNDROME (MDS) NO-HSCT CANDIDATES.” Leukemia research, vol. 39, n.d., pp. S46–. http://access.bl.uk/ark:/81055/vdc_100059908820.0x000001